Synopsis

Source of validity: Scientific
Rating (out of 5): 4

Butyrate triglyceride is a form of butyric acid—a short-chain fatty acid (SCFA) naturally produced in the colon by bacterial fermentation of dietary fibers. While most butyrate research focuses on its effects in the colon, there is growing scientific evidence suggesting that butyrate and its esters (such as butyrate triglyceride) can exert beneficial effects on the small intestine as well. Butyrate has been shown to support the integrity of the intestinal epithelial barrier, reduce inflammation, and promote mucosal healing. These effects are important for maintaining the health of the small intestine, particularly in conditions such as inflammatory bowel diseases or after injury to the gut lining.

Studies in both animals and humans have demonstrated that oral supplementation with butyrate or its triglyceride form can positively influence intestinal permeability and modulate immune responses in the gut. Butyrate is also known to serve as an energy source for enterocytes (intestinal lining cells), contributing to overall gut health. The triglyceride form is designed to protect butyrate from early digestion and allow its release further along the intestinal tract, including the small intestine.

However, while the evidence is promising, most of the robust clinical data concerns colonic health. Research specifically targeting the small intestine is limited but growing. Current scientific validation supports a positive effect, but further clinical trials are needed for conclusive recommendations.

More about butyrate triglyceride
More about Small Intestines

Other ingredients that support Small Intestines

Other body systems supported by butyrate triglyceride

Products containing butyrate triglyceride